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30.7
*O¿VFODF PG TUBHF PGNBUVSBUJPO PG FOHJOFFSFE DBSUJMBHF PO UIF
outcome of osteochondral repair in a goat model
S. Miot1, W. Brehm2, S.C. Dickinson3, A.P. Hollander4, E. Tognana5,
P. Mainil-Varlet6, I. Martin7;
1University Hospital Basel, Institute for Surgical research, Basel, 
Switzerland, 2University Of Bern, Institute of Pathology, Bern, 
Switzerland, 3Clinical Science At North Bristol, University of Bristol, 
Bristol, United Kingdom, 4Department Of Clinical Science At North 
Bristol, University of Bristol Academic Rheumatology, Bristol, 
United Kingdom, 5Fidia, Fidia Advanced Biopolymers, Abano Terme, 
Italy, 6Cro, Allevia AG, Bern, Switzerland, 7Department Of Surgery 
And Of Research, University Hospital Basel, Basel, Switzerland
Purpose: We investigated how the stage of development of 
FOHJOFFSFEDBSUJMBHJOPVT UJTTVFT JO¿VFODFE UIF SFQBJSPVUDPNFPG
large osteochondral defects in a goat model. 
Methods and Materials: Engineered cartilage was generated from 
autologous articular chondrocytes cultured in Hyaff-11[â] meshes 
(FAB) for 2 days, 2 weeks or 6 weeks and implanted on top of 
hydroxyapatite/Hyaff-11[â] sponges into osteochondral defects. 
Experimental settings included defects that were untreated or treated 
with cell-free scaffolds. The repair was assessed histologically and 
biochemically 8 months post implantation. 
Results: GAG and type II collagen contents in engineered tissues 
progressively increased with culture time. Implantation of the 
biomaterial into the subchondral compartment induced an extensive 
SFNPEFMMJOHPG UIFTVSSPVOEJOHCPOF/PTJHOJ¾DBOUEJGGFSFODFTPG
GAG, type-I and -II collagen content between experimental groups 
were observed in the repair tissue overlying the subchondral 
QBSU EVF UP MBSHF FYQFSJNFOUBM WBSJBCJMJUZ .PEJ¾FE 0µ%SJTDPMM
scores indicated poor cartilage repair for untreated and cell-free 
treated groups (29.7±1.6, 24.3±5.8). Instead, in groups using cells, 
improvement in the cartilage repair process was noticed with the 
best scores observed for 2d and 2w preculture time (17.3±8.4, 

 "MUIPVHI UIF SFQBJS UJTTVF XBT TUJMM ¾CSPDBSUJMBHJOPVT
an improvement in the architecture of surface and within the entire 
defect was noticed as compared to the 6w preculture time. 
Conclusions: In this animal model, although the presence of 
QSFDVMUVSFE DIPOESPDZUFT JO UIF HSBGU XBT PG CFOF¾U FYUFOTJWF
maturation of engineered tissues did not enhance the outcome of 
cartilage repair. 
31.3
Meniscus loss during meniscectomy is correlated with clinical 
symptoms, function, and activity levels
W.G. Rodkey1, K.K. Briggs2, J.R. Steadman3;
1Basic Science, Steadman Hawkins Foundation, Vail, CO, United 
States of America, 2Clinical Research, Steadman Hawkins Research 
Foundation, Vail, CO, United States of America, 3Clinical Research, 
Steadman Hawkins Reserach Foundation, Vail, Colorado, United 
States of America
Purpose: No reports quantify amount of meniscus removed at 
meniscectomy and correlate loss with symptoms, function, and activity. 
We determined percent loss at partial meniscectomy and correlated loss 
with symptoms, function, and activity 2 years later. 
Methods and Materials: 149 patients 18 to 60 years old underwent 
partial medial meniscectomy. Eighty-one patients had no prior meniscus 
surgery; 68 had 1 to 3 partial meniscectomies on involved meniscus. At 
index surgery, meniscus defect size was measured and percent meniscus 
loss calculated based on measurements. Patients were followed >2
years. At follow-ups, patients completed Lysholm and Tegner scores to 
assess function and activity. Meniscus remaining at index surgery was 
correlated with individual Lysholm scale domains. Tegner index was 
calculated to determine amount of lost activity regained after 2 years. 
Results: Two-year data were available for 127 (85%) patients. There was 
TJHOJ¾DBOUDPSSFMBUJPOCFUXFFONFOJTDVTBNPVOU SFNBJOJOH GPMMPXJOH
index meniscectomy and 2-year Lysholm domains of squatting (r=0.28, 
p=0.001), stair-climbing (r=0.25, p=0.004), and swelling (r=0.26, 
p=0.003). Patients with > NFOJTDVT SFNBJOJOH IBE TJHOJ¾DBOUMZ
better function than patients with <50%. Patients with worse/no 
improvement in pain symptoms at 2 years averaged 42% meniscus 
remaining; patients with improved pain averaged 51%. Tegner index for 
patients with <50% meniscus remaining averaged 24%; patients with 
>50% meniscus averaged 52% (p=0.02). More meniscus remaining 
BMMPXFEQBUJFOUTUPSFHBJOTJHOJ¾DBOUMZNPSFPGMPTUBDUJWJUZ
Conclusions: Amount of meniscus remaining after meniscectomy 
DPSSFMBUFTTJHOJ¾DBOUMZXJUITZNQUPNT GVODUJPOBOEBDUJWJUZBGUFS
 ZFBST 8F DPO¾SN JNQPSUBODF PG QSFTFSWJOH UIF NFOJTDVT BU
meniscectomy to minimize symptoms of DJD.
31.4
*OEVDUJPOPGFOEPTUBUJOFYQSFTTJPOJONFOTJDBM¾CSPDIPOESPDZUF
by cocultur with endothelial cells
M. Rudert1, W.K. Aicher2, M. Hoberg1;
1Orthopaedics, Technical University Munich, Klinikum rechts der 
Isar, Munich, Germany, 2Orthopaedics, ZMF Research Institute, 
Tuebingen, Germany
Purpose: The highest goal after meniscus damage is the preservation 
of the meniscus. Therefore, the goal of our investigations was 
the analysis of expression of different angiogenic factors, growth 
IPSNPOFTBOEDZUPLJOFTJOIVNBONFOJTDVTDFMMT	¾CSPDIPOESPDZUFT

to examine the molecular bases of the healing of meniscus tears in 
vascularized zones more exactly. 
Methods and Materials: $PDVMUVSFTPGNFOTJDBM¾CSPDIPOESPDZUFT
and HUVEC were analyzed for the expression of Angiopoietin-1, 
Angiopoietin-2, Endostatin, VEGF, SMAD-4, Thrombospondin-1, 
Aggrecan, Biglycan, Fibronectin, Vimentin, Connexin-43, IL-1ß, iNOS, 
MMP-1, MMP-3, MMP-13, collagen-I, -II, -III, -VI, X, and -XVIII by RT-
PCR and immunhistochemistry. A proliferation assay was used to 
investigate the mitotic activity after 4 and 12 days. 
Results: *O QSFTFODF PG )67&$ NFOJTDBM ¾CSPDIPOESPDZUFT
expressed the following factors at rates comparable to cells w/o 
HUVECS: Angiopoietin-1, Angiopoietin-2, VEGF, SMAD-4, Aggrecan, 
Biglycan, Fibronectin, Vimentin, Connexin-43, iNOS, MMP-1, MMP-
3, MMP-13, Thrombostatin-1, collagen-I, -II, -III, -VI, X, and -XVIII. 
The expression of endostatin (5.1-fold ± 1.2, p< 0.01) and IL-1ß 
(10.3-fold ± 2.3, p<
 XFSF FYQSFTTFE TJHOJ¾DBOUMZ IJHIFS JO
UIF DPDVMUVSFBOE IF QSPMJGFSBUJPO SBUF PG )67&$XBT TJHOJ¾DBOUMZ
decreased in coculture: 22 % after 7 days and 35 % after 14 days 
(p<0.001). 
Conclusions: We could show that coculture of meniscus cells with 
endothelial cells revealed an increased expression of the anti-
BOHJPHFOFUJD GBDUPS FOEPTUBUJO BOE UIF QSPJO¿BNNBUPSZ *-
This suggests that meniscus cells are trying to inhibit proliferation 
of endothelial cells in their neigbourhood, which implicates huge 
QSPCMFNT JO UIF SFTFBSDI ¾FME PG OFPBOHJPHFOJTJT BOE UJTTVF
engineering in meniscus tissue. 
31.5
Collagen Meniscus Implant (CMI) - treated patients have increased 
activity levels after two years
W.G. Rodkey1, K.K. Briggs2, J..R. Steadman3;
1Basic Science, Steadman Hawkins Foundation, Vail, CO, United 
States of America, 2Clinical Research, Steadman Hawkins Research 
Foundation, Vail, CO, United States of America, 3Clinical Research, 
Steadman Hawkins Reserach Foundation, Vail, Colorado, United 
States of America
Purpose: 8F SFQPSUFE TJHOJ¾DBOU DPSSFMBUJPO CFUXFFO BDUVBM
measured amounts of meniscus tissue removed at meniscectomy and 
symptoms, function and activity 2 years after surgery. Patients with 
>SFNBJOJOHNFOJTDVTXFSFTJHOJ¾DBOUMZCFUUFSJOBMMDBUFHPSJFT
than patients with <50% remaining. We determined, prospectively, 
changes in Tegner scores from preoperative to 2 years postoperative 
in patients who received Collagen Meniscus Implants (CMI) and had 
>50% meniscus at 1-year relook. 
Methods and Materials: In a Level of Evidence I clinical trial, 138 
patients 18 to 60 years old underwent partial medial meniscectomy 
and placement of CMI. Sixty-four had no prior meniscus surgery and 
74 had 1 to 3 prior partial meniscectomies. At index surgery, meniscus 
defect size was measured and percent meniscus loss calculated. 
Relook arthroscopy was performed at 1 year on 124 patients (90%), 
BOE QFSDFOU NFOJTDVT 	SFNOBOU  OFX UJTTVF
 XBT EFUFSNJOFE
Patients were followed >2 years after CMI placement. At follow-up, 
patients completed a Tegner activity score. We determined changes 
in Tegner from index surgery to 2 years F/U. 
Results: 111 patients (90%) had >50% total meniscus tissue. Their 
average Tegner scores improved two levels from 3 to 5 over 2 years. 
5IJT JODSFBTFEBDUJWJUZ MFWFM TJHOJ¾DBOUMZ DPSSFMBUFEXJUINFOJTDVT
tissue >50% (r=0.21, p=0.02). 
Conclusions: 5IFSF JT TJHOJ¾DBOU DPSSFMBUJPO CFUXFFO JODSFBTF
in Tegner scores over 2 years and percent meniscus tissue in CMI 
patients who have > NFOJTDVT 8F DPO¾SNFE JNQPSUBODF
of preserving as much meniscus as possible at time of repair or 
NFOJTDFDUPNZ %BUB TVQQPSU UIF QPUFOUJBM QPTJUJWF CFOF¾UT PG
regenerating meniscus tissue. 
